Back
ESC Premium Access

Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study

Session: Cardiovascular Disease in Special Populations ePosters
Topic: Renal Failure and Cardiovascular Disease
Speaker: Professor M. Gwechenberger (Vienna, AT)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Professor Marianne Gwechenberger

Medical University of Vienna, Vienna (Austria)
2 presentations
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Access
Abstract
Slides
Like
Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Professor M. Gwechenberger, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources